Biotech
ImmVira's MVR-T3011 Obtained NMPA's Approval for Intravenous Administration (IV) Phase I Clinical Trial
SHENZHEN, China, Aug. 6, 2021 /PRNewswire/ -- ImmVira announced that as a global first, its lead oncolytic virus therapy program MVR-T3011 IV (also known as T3011), obtained approval from National Medical Products Administration (" NMPA") for clinical trial for treatments using intravenous adminis...
Taiwan's medical device company challenges the limit of science, launching the most expensive collagen in the contemporary market
TAIPEI, Aug. 6, 2021 /PRNewswire/ -- As consumers around the world increase their awareness of using beauty and health products, collagen products have become the most popular item. Various manufacturers continue to innovate in accordance with consumer demand. According to Research and Markets, w...
Firmenich Reports Solid Full Year Results With Accelerating Momentum in the Second Half
GENEVA, Aug. 6, 2021 /PRNewswire/ -- Firmenich International SA, the world's largest privately-owned Perfume and Taste company, announces its Full Year Results for the 52 weeks ended30 June 2021. Financial Highlights * Revenue reached CHF 4,272 million, up 4.7% year-over-year on an organic ...
SURGLASSES' SPINE NAVIGATION SYSTEM CADUCEUS S - An innovation greatly influencing minimally invasive surgeries
TAICHUNG, Aug. 6, 2021 /PRNewswire/ -- Taiwan Main Orthopaedic Biotechnology Co. Ltd (SURGLASSES),Taiwan, a company striving to bring a difference into the real time surgical procedure after the introduction of the first AR assisted Head Mounted Display Foresee-X, is now coming up with a new prod...
Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination
* Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series * Six-fold increase in cross-reactive functional antibodies to Delta variant compared to primary vaccination series * Analysis of sera from primary ...
Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Vaccine
- Novavax and Serum Institute of India file regulatory submissions to the Drugs Controller General ofIndia and to regulatory agencies in Indonesia and Philippines for Novavax' recombinant nanoparticle COVID-19 vaccine - Filing for World Health Organization Emergency Use Listing expected in Augus...
Advanced Instruments to Acquire Solentim, a Trusted Global Leader in Cell Imaging for Cell Line Development and Clone Characterization
NORWOOD, Mass., Aug. 6, 2021 /PRNewswire/ -- Advanced Instruments, a leading manufacturer of analytical instruments and services for bioprocessing, today announced the execution of a definitive agreement to acquire Solentim, a trusted global leader of solutions for the isolation and characterizat...
Brii Biosciences Announces the Completion of Enrollment in the Phase 3 National Institutes of Health (NIH) ACTIV-2 Trial, Evaluating the BRII-196 and BRII-198 Monoclonal Neutralizing Antibody Combination for the Treatment of COVID-19
846 outpatients at high risk of clinical progression have been enrolled in the ACTIV-2 phase 2/3 clinical study, from sites inthe United States, Brazil, South Africa, Mexico and Argentina. The participants are being evaluated for the combined endpoint of hospitalizations and death relative ...
China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval
HAIKOU, China, Aug. 5, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that its Candesartan hypertension product passed key bioequivalence tests. The Company plans to use the result...
Insilico Medicine and Usynova Announce Strategic Partnership on Accelerating R&D of Small Molecule Innovative Drugs with AI
SHANGHAI, Aug. 5, 2021 /PRNewswire/ -- Insilico Medicine, an industry leader in
end-to-end artificial intelligence for target discovery, small molecule
chemistry, and clinical development, and Usynova announced to reach strategic
cooperation in advancing the development of novel therapies.
Traveloka, Southeast Asia's lifestyle superapp, recognized by Fast Company as a Best Workplace for Innovators
JAKARTA, Indonesia, Aug. 5, 2021 /PRNewswire/ -- Traveloka, Southeast Asia's lifestyle superapp, has been recognized by Fast Company as an outstanding international Best Workplace for Innovators. The 2021 Best Workplaces for Innovators list, which includes more than 100 companies selected from ne...
Inmagene and Kissei Enter into an Exclusive License Agreement for Fostamatinib in China
SHANGHAI and SAN DIEGO and NAGANO, Japan, Aug. 5, 2021 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene") and Kissei Pharmaceutical Co., Ltd. ("Kissei") announced today that they have entered into an exclusive license agreement for the development and commercialization of fostamatinib in ma...
Isobar Named to Fast Company's 2021 List of the 100 Best Workplaces for Innovators
The digital experience agency joins Google, Samsung, IBM, General Motors, Moderna, and others on prestigious annual list LONDON, Aug. 5, 2021 /PRNewswire/ -- Fast Company today announced its third annual Best Workplaces for Innovators list, honoring businesses and organizations that demonstrate ...
ABL Bio Receives IND Approval for Phase 1 Clinical Trial of ABL501, an anti-LAG-3/PD-L1 Bispecific Antibody
* South Korea's MFDS clears IND application for a Phase 1 study evaluating the safety and preliminary efficacy of ABL501 as a monotherapy for solid tumor treatment * ABL's third IND this year for bispecific antibody therapeutics SEONGNAM, South Korea, Aug. 4, 2021 /PRNewswire/ -- ABL Bio, Inc...
Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine
GAITHERSBURG, Md., Aug. 4, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has reached an agreement with the European Commission (EC) for the purchase of up to 200 million doses...
Alterity Therapeutics Announces New US Patent to Expand its Portfolio of Compounds for Neurodegenerative Diseases including Alzheimer's and Parkinson's
MELBOURNE, Australia, Aug. 4, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today announced the United States Patent and Trademark Of...
Insilico Medicine Announces the Preclinical Candidate for Kidney Fibrosis Discovered Using End-to-End Artificial Intelligence Engine
HONG KONG, Aug. 4, 2021 /PRNewswire/ -- Insilico Medicine, a global company specializing in the applications of the next-generation machine learning technologies for drug discovery and development, announced today that its AI-powered drug discovery platform had delivered the preclinical candidate...
Varigard Technologies Proven to Prevent the Tactile Spread of SARS-CoV-2, B.1.617.2 - DELTA Variant
Varigard's protective Hand Sanitizing lotion prevents the tactical spread of SARS-CoV-2, B.1.617.2 for two hours and for over 20 hours with its organic Surface Spray FOLEY, Ala., Aug. 3, 2021 /PRNewswire/ -- Varigard and Synergy Laboratories have announced the test results of an advanced hand sa...
Clinical Trial Affirms CoviDTH Diagnostic Approach to screen for T cell-mediated immune response to SARS-CoV-2 is safe and effective in humans
Yvelise Barrios, MD, PhD, Immunologist and leading expert in the clinical use of delayed type hypersensitivity ("DTH"), the mechanism behindCoviDTH, joins BioVaxys as scientific adviser VANCOUVER, BC and SAN CRISTÓBAL DE LA LAGUNA, Spain, Aug. 3, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (C...
Angel Yeast Reports Strong Revenue Growth in First Half of 2021, Achieves 20.55% YoY Increase
YICHANG, China, Aug. 3, 2021 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast
")(en.angelyeast.com
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 326 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 321 media titles]
2024-05-15 12:00
Innomix and World Castle Association Pioneer LBMR project at Zhangbi Fortress
[Picked up by 309 media titles]
2024-05-20 13:48
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 308 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 278 media titles]
2024-05-16 09:39
Most Read
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
Casio to Release G-SHOCK-Surfrider Foundation Collaboration
